News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
647,847 Results
Type
Article (20790)
Company Profile (216)
Press Release (626833)
Multimedia
Podcasts (59)
Webinars (14)
Section
Business (212481)
Career Advice (714)
Deals (32057)
Drug Delivery (70)
Drug Development (64980)
Employer Resources (58)
FDA (13550)
Job Trends (11802)
News (301689)
Policy (23337)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (21)
2027 BioCapital Standard (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (1581)
Accelerated approval (41)
ADA (26)
Adcomms (2)
Allergies (174)
Alliances (47362)
ALS (180)
Alzheimer's disease (1366)
Antibody-drug conjugate (ADC) (525)
Approvals (14457)
Artificial intelligence (844)
ASCO (210)
Autoimmune disease (360)
Automation (70)
Bankruptcy (302)
Belgium (30)
Best Places to Work (9419)
BIO (53)
Biologics (98)
BIOSECURE Act (7)
Biosimilars (186)
BioSpace Insights (105)
Biotechnology (138)
Bispecific (49)
Bladder cancer (186)
Brain cancer (64)
Breast cancer (705)
Cancer (5690)
Cardiovascular disease (375)
Career advice (629)
Career pathing (14)
CAR-T (349)
CDC (15)
CDMO (138)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (911)
Cervical cancer (55)
Clinical research (58791)
Collaboration (2345)
Commercialization (54)
Company closure (1)
Compensation (1728)
Complete response letters (45)
COVID-19 (1554)
CRISPR (137)
CRO (4)
C-suite (1311)
Cystic fibrosis (130)
Data (8747)
Decentralized trials (3)
Denatured (29)
Depression (134)
Dermatology (136)
Diabetes (532)
Diagnostics (6769)
Digital health (74)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (366)
Drug pricing (26)
Drug shortages (8)
Duchenne muscular dystrophy (224)
Earnings (86076)
Editorial (12)
Employer branding (9)
Employer resources (54)
ESMO (316)
Events (111191)
Executive appointments (1105)
Eye disease (25)
FDA (17702)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (3)
Friedreich's ataxia (23)
Frontotemporal dementia (34)
Funding (1765)
Gene editing (267)
Generative AI (64)
Gene therapy (660)
GLP-1 (551)
Government (1882)
Grass and pollen (4)
Guidances (366)
Healthcare (14788)
Hematology (153)
HIV (86)
Huntington's disease (37)
Idiopathic pulmonary fibrosis (7)
IgA nephropathy (98)
Immunology and inflammation (161)
Immuno-oncology (98)
Indications (243)
Infectious disease (1866)
Inflammatory bowel disease (185)
Inflation Reduction Act (7)
Influenza (136)
Intellectual property (345)
Interviews (87)
IPO (15039)
IRA (10)
Job creations (2765)
Job search strategy (563)
JPM (23)
Kidney cancer (22)
Kidney disease (115)
Labor market (34)
Layoffs (188)
Leadership (10)
Legal (6055)
Licensing (101)
Liver cancer (78)
Longevity (44)
Lung cancer (732)
Lung diease (15)
Lymphoma (395)
Machine learning (64)
Management (21)
Manufacturing (1183)
Marketing (33)
MASH (157)
Medical affairs (3)
Medical device (13860)
Medtech (14189)
Mergers & acquisitions (18477)
Metabolic disorders (1080)
Middle East (1)
mRNA (243)
Multiple sclerosis (181)
Multispecific (6)
NASH (7)
Netherlands (20)
Neurodegenerative disease (390)
Neuropsychiatric disorders (58)
Neuroscience (2767)
Neurotech (2)
NextGen: Class of 2026 (5085)
Non-profit (2080)
Now hiring (27)
Obesity (347)
Opinion (126)
Ovarian cancer (224)
Pain (249)
Pancreatic cancer (336)
Parkinson's disease (332)
Partnered (28)
Patents (676)
Patient advocacy (6)
Patient recruitment (773)
Patient selection (81)
Peanut (67)
People (54069)
Peptides (32)
Pharmaceutical (41)
Pharmacy benefit managers (16)
Phase 1 (19443)
Phase 2 (26245)
Phase 3 (17818)
Pipeline (12066)
Policy (88)
Postmarket research (1764)
Preclinical (8357)
Press Release (70)
Prostate cancer (305)
Psychedelics (18)
Radioligand (1)
Radiopharmaceuticals (361)
Rare diseases (894)
Real estate (4925)
Recruiting (25)
Regenerative medicine (30)
Regulatory (20440)
Reports (40)
Research institute (1614)
Resumes & cover letters (107)
Rett syndrome (55)
RNA editing (25)
RSV (70)
Saudi Arabia (1)
Schizophrenia (132)
Series A (323)
Series B (217)
Service/supplier (6)
Sickle cell disease (87)
Special edition (2)
Spinal muscular atrophy (114)
Sponsored (28)
Startups (3337)
State (2)
Stem cells (6)
Stomach cancer (5)
Substance use disorders (18)
Supply chain (92)
Switzerland (12)
Tariffs (16)
The Weekly (28)
Vaccines (774)
Venture capital (76)
Weight loss (130)
Wet AMD (7)
Women's health (133)
Worklife (4)
Date
Today (141)
Last 7 days (706)
Last 30 days (3178)
Last 365 days (25918)
2026 (23516)
2025 (25407)
2024 (30350)
2023 (35034)
2022 (45489)
2021 (48936)
2020 (45896)
2019 (36625)
2018 (27513)
2017 (27426)
2016 (26456)
2015 (32960)
2014 (27945)
2013 (23893)
2012 (25816)
2011 (26168)
2010 (25013)
Location
Africa (463)
Alabama (97)
Alaska (7)
Arizona (405)
Arkansas (17)
Asia (34407)
Australia (5367)
California (15418)
Canada (4146)
China (1308)
Colorado (694)
Connecticut (616)
Delaware (357)
Europe (66158)
Florida (2320)
Georgia (502)
Hawaii (4)
Idaho (60)
Illinois (1179)
India (124)
Indiana (485)
Iowa (30)
Japan (696)
Kansas (137)
Kentucky (52)
Louisiana (46)
Maine (40)
Maryland (1695)
Massachusetts (10748)
Michigan (434)
Minnesota (832)
Mississippi (7)
Missouri (159)
Montana (32)
Nebraska (19)
Nevada (165)
New Hampshire (90)
New Jersey (3624)
New Mexico (27)
New York (3868)
North Carolina (1862)
North Dakota (13)
Northern California (7786)
Ohio (441)
Oklahoma (24)
Oregon (32)
Pennsylvania (2916)
Puerto Rico (32)
Rhode Island (61)
South America (736)
South Carolina (100)
South Dakota (1)
Southern California (6379)
Tennessee (222)
Texas (2574)
United States (52614)
Utah (478)
Vermont (2)
Virginia (264)
Washington D.C. (53)
Washington State (1242)
West Virginia (3)
Wisconsin (174)
Wyoming (2)
647,847 Results for "visioncare ophthalmic technologies inc visioncare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OpZira™, Inc. Selected to Present Ophthalmic Device Technologies at 2026 New York Venture Summit
November 3, 2026
·
2 min read
Press Releases
UPSHER-SMITH LAUNCHES TWO STRENGTHS OF BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
November 10, 2026
·
2 min read
Press Releases
Verana Health and Bitfount Collaborate to Simplify Prescreening for Ophthalmic Clinical Trials
October 8, 2026
·
3 min read
Press Releases
ZEISS demonstrates new digital and visual enhancements across ophthalmic workflows at AAO
October 6, 2026
·
13 min read
Press Releases
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
September 29, 2026
·
1 min read
Press Releases
Iantrek Expands Clinical Evidence for Bio-Interventional Ophthalmic Surgery Across Trabecular and Uveoscleral Outflow Pathways
October 8, 2026
·
4 min read
Press Releases
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
October 18, 2026
·
6 min read
Press Releases
ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
September 3, 2026
·
9 min read
Press Releases
PharmFormulator LLC Launches Intelligence Platform to Bring Unprecedented Transparency to Ophthalmic Inactive Ingredients
September 24, 2026
·
1 min read
Press Releases
Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London
September 10, 2026
·
4 min read
1 of 64,785
Next